Illuminatio Medical Technology

Revolutionizing Early Disease Detection Through Advanced MRI Technology Illuminatio Medical Technology (IMT) is a pioneering medical imaging company that transforms standard MRI scanners into powerful diagnostic tools for early disease detection. Our breakthrough technology quantifies macromolecule levels in human tissues—solving a critical challenge in traditional MRI imaging. What Sets Us Apart: • No Additional Hardware Required: Our patented pulse sequence innovation works with existing MRI systems • Contrast-Free Solution: Non-invasive assessment without contrast agent injections • Seamless Clinical Integration: Cost-effective workflow that fits naturally into clinical routines • AI Research Platform: Advanced post-processing software accelerates research-to-clinic translation Addressing Critical Healthcare Needs: Our first commercial application targets liver fibrosis assessment, a crucial need affecting nearly 25% of the global population. With chronic liver disease creating substantial clinical and economic burdens worldwide, our non-invasive solution enables early, accurate diagnosis through MRI to guide treatment decisions and improve patient outcomes. Our Vision: We deliver comprehensive imaging diagnostic solutions to MRI manufacturers, healthcare providers, researchers, and clinical practitioners, bridging the gap between cutting-edge research and real-world clinical applications. Founded in 2021 by a multidisciplinary team from The Chinese University of Hong Kong, combining expertise in medical imaging engineering, clinical radiology, and business operation. Transforming MRI capabilities. Advancing patient care. Accelerating medical discovery.

• Employees 6
• Founded 2021